Page last updated: 2024-08-23

tobramycin and moxifloxacin

tobramycin has been researched along with moxifloxacin in 39 studies

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's16 (41.03)29.6817
2010's17 (43.59)24.3611
2020's6 (15.38)2.80

Authors

AuthorsStudies
Duewelhenke, N; Eysel, P; Krut, O1
Courvalin, P; Galimand, M; Périchon, B1
Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A1
Lombardo, F; Obach, RS; Waters, NJ1
Cattoir, V; Nordmann, P; Poirel, L1
del Pozo, JL; Mandrekar, JN; Patel, R; Rouse, MS; Sampedro, MF; Steckelberg, JM1
Choi, SH; Jeong, JY; Jun, JB; Kim, ES; Kim, MN; Kim, YS; Lee, SO; Woo, JH1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H1
Fernando, DM; Gorityala, BK; Goswami, S; Guchhait, G; Kumar, A; Schweizer, F; Zhanel, GG1
Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG1
Lee, SB; Mohan, SK; Oliver, KM; Slomovic, AR; Strube, YN1
Alfonso, EC; Karp, CL; Miller, D; Munir, WM; Rosenfeld, SI; Udell, I1
Jhanji, V; Satpathy, G; Sharma, N; Titiyal, J1
Constantinou, M; Daniell, M; Snibson, GR; Taylor, HR; Vu, HT1
Eisen, L; Kim, J; Rosenberg, J1
Giannoni, AG; Miller, WL; Perrigin, J1
del Pozo, JL; Mandrekar, JN; Patel, R; Rouse, MS; Steckelberg, JM1
Agarwal, T; Chawla, B; Nayak, N; Satpathy, G; Shah, VM; Sharma, N; Tandon, R; Titiyal, JS; Vajpayee, RB1
Brooks, CW; Demartelaere, SL; Johnson, AJ1
Alfonso, EC; Almeida, DR; Miller, D1
Bansal, S; Sachdev, R; Sharma, N; Sinha, R; Titiyal, JS1
Karenchak, LM; Kowalski, RP; Kowalski, TA; Mah, FS; Romanowski, EG; Shanks, RM1
Agarwal, P; Bansal, S; Goel, M; Sharma, N; Titiyal, JS; Upadhyaya, AD; Vajpayee, RB1
Blanco, AR; Papa, V; Spoto, CG; Sudano Roccaro, A1
Ohashi, Y; Suzuki, T1
Baviera, J; Beltran, J; Djodeyre, MR; Llovet-Osuna, F; Llovet-Rausell, A; Ortega-Usobiaga, J1
Fulcher, LC; Johnson, D; Jorgensen, J; Kiel, JW; McElmeel, ML; Montes, JA1
Gregory, DG1
Borgman, CJ1
Atta, S; Bhat, AK; Dhaliwal, D; Durrani, AF; Jhanji, V; Kowalski, RP; Mammen, A1
Chhabria, M; Kudaravalli, P; Lesho, E; Pendela, VS1
Bhamare, P; Dunman, PM; Johnson, W; Kinn, B; Laskey, E; Mei, JA; Nolin, L; Stalker, C; Wozniak, RAF1
Berry, N; Byrne, DP; Fernig, DG; Foulkes, DM; Haneef, AS; Kaye, SB; McLean, K; Rustidge, S; Sloniecka, M; Winstanley, C1
Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA1
Ding, Y; Jiang, M; Wan, X; Xie, F; Zhang, J1

Trials

3 trial(s) available for tobramycin and moxifloxacin

ArticleYear
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Ophthalmology, 2007, Volume: 114, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Child; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ofloxacin; Prospective Studies; Quinolines; Tobramycin; Treatment Outcome

2007
Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
    Cornea, 2010, Volume: 29, Issue:7

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefazolin; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Tobramycin; Treatment Outcome; Visual Acuity; Young Adult

2010
Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
    Ophthalmology, 2013, Volume: 120, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefazolin; Cornea; Corneal Ulcer; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Prevalence; Prospective Studies; Quinolines; Therapeutic Equivalency; Tobramycin; Treatment Outcome; Visual Acuity

2013

Other Studies

36 other study(ies) available for tobramycin and moxifloxacin

ArticleYear
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors

2007
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid

2007
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids

2008
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Anti-Infective Agents; Biofilms; Bioreactors; Electricity; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis

2009
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Acetyltransferases; beta-Lactamases; Ciprofloxacin; Conjugation, Genetic; Enterobacteriaceae; Microbial Sensitivity Tests; Plasmids

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare

2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction

2010
Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux.
    Journal of medicinal chemistry, 2016, 09-22, Volume: 59, Issue:18

    Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2016
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
    Journal of medicinal chemistry, 2017, 05-11, Volume: 60, Issue:9

    Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin

2017
Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2005, Volume: 40, Issue:6

    Topics: Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Quinolines; Surgical Flaps; Tobramycin

2005
Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy.
    Cornea, 2007, Volume: 26, Issue:5

    Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Ascomycota; Aza Compounds; Cefazolin; Contact Lenses; Cornea; Corneal Ulcer; Eye Infections, Fungal; Female; Fluoroquinolones; Fusarium; Humans; Male; Microscopy, Confocal; Moxifloxacin; Mycoses; Natamycin; Ophthalmic Solutions; Quinolines; Tobramycin

2007
Fourth-generation fluoroquinolone-resistant bacterial keratitis.
    Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin

2007
Moxifloxacin for bacterial keratitis.
    Ophthalmology, 2008, Volume: 115, Issue:6

    Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Ofloxacin; Quinolines; Randomized Controlled Trials as Topic; Tobramycin; Treatment Outcome

2008
A case of fungal keratitis: a clinical and in vivo confocal microscopy assessment.
    Contact lens & anterior eye : the journal of the British Contact Lens Association, 2008, Volume: 31, Issue:4

    Topics: Adult; Anti-Infective Agents; Antifungal Agents; Aza Compounds; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Fluoroquinolones; Fusarium; Humans; Male; Microscopy, Confocal; Moxifloxacin; Mycoses; Natamycin; Quinolines; Tobramycin

2008
The electricidal effect: reduction of Staphylococcus and pseudomonas biofilms by prolonged exposure to low-intensity electrical current.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Aza Compounds; Biofilms; Electricity; Fluoroquinolones; Moxifloxacin; Pseudomonas; Quinolines; Staphylococcus; Tobramycin

2009
Spontaneous subconjunctival abscess because of Haemophilus influenzae.
    Cornea, 2010, Volume: 29, Issue:7

    Topics: Abscess; Adult; Anti-Infective Agents; Aza Compounds; Conjunctival Diseases; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Moxifloxacin; Quinolines; Tobramycin; Tomography, X-Ray Computed; Vancomycin

2010
Tsukamurella: an emerging opportunistic ocular pathogen.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2010, Volume: 45, Issue:3

    Topics: Actinomycetales; Actinomycetales Infections; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Conjunctivitis, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Opportunistic Infections; Quinolines; Tobramycin

2010
Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case series.
    Ocular immunology and inflammation, 2011, Volume: 19, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amnion; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Aza Compounds; Benzamidines; Carboxymethylcellulose Sodium; Cefazolin; Chlorhexidine; Corneal Ulcer; Drug Therapy, Combination; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pain; Quinolines; Stevens-Johnson Syndrome; Tobramycin; Treatment Outcome; Tropanes; Visual Acuity

2011
In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
    Cornea, 2013, Volume: 32, Issue:6

    Topics: Anti-Bacterial Agents; Aza Compounds; Cefazolin; Cefuroxime; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Incidence; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Tobramycin

2013
Susceptibility of methicillin-resistant Staphylococci clinical isolates to netilmicin and other antibiotics commonly used in ophthalmic therapy.
    Current eye research, 2013, Volume: 38, Issue:8

    Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Chloramphenicol; Drug Resistance; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Netilmicin; Quinolines; Staphylococcus epidermidis; Tobramycin; Vancomycin

2013
Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index.
    Cornea, 2013, Volume: 32, Issue:7

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefmenoxime; Corneal Ulcer; Drug Combinations; Drug Synergism; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Pseudomonas; Quinolines; Staphylococcus; Streptococcus; Tobramycin

2013
Incidence of corneal infections after laser in situ keratomileusis and surface ablation when moxifloxacin and tobramycin are used as postoperative treatment.
    Journal of cataract and refractive surgery, 2015, Volume: 41, Issue:6

    Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Incidence; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Middle Aged; Moxifloxacin; Myopia; Ophthalmic Solutions; Postoperative Complications; Retrospective Studies; Risk Factors; Tobramycin; Visual Acuity; Young Adult

2015
Potency and Sterility of Fortified Tobramycin, Fortified Vancomycin, and Moxifloxacin at 4, 24, and 35°C for 14 Days.
    Cornea, 2016, Volume: 35, Issue:1

    Topics: Anti-Bacterial Agents; Drug Stability; Drug Storage; Eye Infections, Bacterial; Fluoroquinolones; Follow-Up Studies; Humans; Infertility; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Prospective Studies; Temperature; Time Factors; Tobramycin; Vancomycin

2016
New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome.
    Ophthalmology, 2016, Volume: 123, Issue:8

    Topics: Acute Disease; Amnion; Anti-Bacterial Agents; Combined Modality Therapy; Cyclosporine; Dexamethasone; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorophotometry; Fluoroquinolones; Glucocorticoids; Guidelines as Topic; Humans; Middle Aged; Moxifloxacin; Prospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome; Tobramycin; Visual Acuity

2016
Recurrent conjunctivitis secondary to Gram-positive bacillus, Bacillus thuringiensis.
    Clinical & experimental optometry, 2018, Volume: 101, Issue:4

    Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Bacillus thuringiensis; Conjunctivitis, Bacterial; Dexamethasone; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Recurrence; Tobramycin

2018
Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes.
    American journal of ophthalmology, 2020, Volume: 214

    Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Corneal Ulcer; Drug Combinations; Eye Infections, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Retrospective Studies; Risk Factors; Staphylococcal Infections; Tobramycin; Treatment Outcome; Vancomycin

2020
Case Report: A Polymicrobial Vision-Threatening Eye Infection Associated with Polysubstance Abuse.
    The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:2

    Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Ceftazidime; Cocaine; Cocaine-Related Disorders; Coinfection; Dopamine Uptake Inhibitors; Doxycycline; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Kingella; Linezolid; Moxifloxacin; Neisseriaceae Infections; Ophthalmic Solutions; Prednisone; Propionibacterium acnes; Streptococcal Infections; Streptococcus; Substance Abuse, Intravenous; Tobramycin; Vancomycin; Voriconazole

2020
Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates.
    Translational vision science & technology, 2022, 05-02, Volume: 11, Issue:5

    Topics: Anti-Bacterial Agents; Bacitracin; Drug Combinations; Erythromycin; Framycetin; Humans; Keratitis; Levofloxacin; Moxifloxacin; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Tobramycin; Trimethoprim

2022
Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicity.
    The Biochemical journal, 2022, 12-22, Volume: 479, Issue:24

    Topics: ADP Ribose Transferases; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Fluoroquinolones; Genotype; Humans; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence Factors

2022
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin

2023
Conjunctival sac flora and drug susceptibility analysis in normal children in East China.
    BMC ophthalmology, 2023, Jun-02, Volume: 23, Issue:1

    Topics: Anti-Bacterial Agents; Child; Child, Preschool; Conjunctiva; Female; Gatifloxacin; Humans; Lacrimal Apparatus; Male; Microbial Sensitivity Tests; Moxifloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus; Tobramycin

2023